Lazard Asset Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-3,368
Closed -$146K – 2461
2023
Q1
$146K Buy
3,368
+197
+6% +$8.7K ﹤0.01% 1401
2022
Q4
$118K Buy
3,171
+760
+32% +$29.4K ﹤0.01% 1464
2022
Q3
$95K Buy
2,411
+825
+52% +$30.5K ﹤0.01% 1494
2022
Q2
$60K Buy
1,586
+338
+27% +$12.2K ﹤0.01% 1731
2022
Q1
$49K Buy
+1,248
New +$48.9K ﹤0.01% 1749

Other funds holding NRC

Lazard Asset Management's NRC Position: Q2 2023 in Review

Lazard Asset Management sold out of NRC Health Common Stock (NRC) in Q2 2023, closing a stake of 3,368 shares — an estimated $146K sold.

Lazard Asset Management first reported a position in NRC in Q1 2022 and held it in 5 quarters. The position peaked at $146K in Q1 2023. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

  • Lazard Asset Management reported no remaining NRC Health Common Stock position as of Q2 2023 after selling out during the quarter.
  • Lazard Asset Management sold 3,368 NRC Health Common Stock shares in Q2 2023, an estimated $146K.
  • Lazard Asset Management first reported a position in NRC Health Common Stock in Q1 2022 and held it in 5 quarters.
  • Lazard Asset Management's NRC Health Common Stock position peaked at $146K in Q1 2023.
  • 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.